๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Radical formation site of cerebral complex I and Parkinson's disease

โœ Scribed by T. Fukushima; T. Tawara; A. Lsobe; N. Hojo; K. Shiwaku; Y. Yamane


Book ID
102911599
Publisher
John Wiley and Sons
Year
1995
Tongue
English
Weight
507 KB
Volume
42
Category
Article
ISSN
0360-4012

No coin nor oath required. For personal study only.

โœฆ Synopsis


Abstract

Paraquat was reduced to the paraquat radical via complex I in bovine cerebral mitochondria and accelerated lipid peroxidation. Thirtyโ€kilodalton subunit of complex I was considered to be the radical formation site, because of its marked destruction by the paraquat radical. The lipid peroxidation by the paraquat radical was suppressed not only by superoxide dismutase (SOD) but also by mannitol. The destruction of complex I subunits via lipid peroxidation must have been caused by the hydroxyl radical which was formed from the superoxide radical. The same phenomenon was observed by using 1โ€methylnicotinamide (MNA), which contains the same partial structure as paraquat in itself and is metabolized from nicotinamide in a living body. We observed NADH oxidation by MNA via cerebral complex I (Km = 26.3 mM), and MNA destroyed some complex I subunits, especially 30โ€kilodalton protein. Paraquat might be useful for studying the pathogenesis of Parkinson's disease (PD) in vitro, and MNA is expected to be one of the causal substances of PD from the viewpoint of the oxidative stress theory. ยฉ 1995 Wileyโ€Liss, Inc.


๐Ÿ“œ SIMILAR VOLUMES


Complex I and Parkinson's Disease
โœ J. Timothy Greenamyre; Todd B. Sherer; Ranjita Betarbet; Alexander V. Panov ๐Ÿ“‚ Article ๐Ÿ“… 2001 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 163 KB
Parkinson's Disease || Complex I Inhibit
โœ Betarbet, Ranjita ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› Elsevier ๐ŸŒ English โš– 216 KB

Parkinsonโ€™s disease is the second most prevalent neurodegenerative disease and is characterized by the irreversible loss of dopamine neurons. Despite its high prevalence in society and many decades of research, the origin of the pathogenesis and the molecular determinants involved in the disorder ha

L-Dihydroxyphenylalanine and complex I d
โœ J. M. Cooper; S. E. Daniel; C. D. Marsden; Prof. A. H. V. Schapira ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 305 KB

There is evidence for a 37% deficiency of complex I activity in Parkinson's disease (PD), which appears to be specific for PD amongst parkinsonian syndromes and selective for the substantia nigra within the central nervous system. Rat studies have shown that, in the context of a normal nigrostriatal